About UCDs
Onset
Treatment Guidelines
AMMONUL
(sodium phenylacetate and sodium benzoate)
Injection 10%/10%
Indication & Usage
Prescribing Information
Clinical Pharmacology
Efficacy
Safety
Dosage & Administration
How Supplied
BUPHENYL
(sodium phenylbutyrate)
Tablets and Powder
Indication & Usage
Prescribing Information
Clinical Pharmacology
Dosage & Administration
How Supplied
Ordering Information
UCD Resources
UCD Research
Patient Assistance
AMMONUL
(sodium phenylacetate and sodium benzoate)
Injection 10%/10%
Filtration of AMMONUL
BUPHENYL
(sodium phenylbutyrate)
Tablets and Powder
AMMONUL
(sodium phenylacetate and sodium benzoate)
Injection 10%/10%
BUPHENYL
(sodium phenylbutyrate)
Tablets and Powder
References
Summar M, Tuchman M. Proceedings of a consensus conference for the management of patients with urea cycle disorders.
J Pediatr
. 2001 Jan;138(1 Suppl):S6–10.
Summar M. Current strategies for the management of neonatal urea cycle disorders.
J Pediatr
. 2001 Jan;138(1 Suppl):S30–9.
Rare Diseases Clinical Research Network. Urea Cycle Disorders Consortium. Treatment guidelines. http://rarediseasesnetwork.epi.usf.edu/ucdc/physicians/guidelines-main.htm. Last accessed March 6, 2012.
NDA 20-645 for AMMONUL Injection; Vol 1, Page 5. June 2004. Data on file, Ucyclyd Pharma, Inc.
NDA 20-645 for AMMONUL Injection; Comprehensive Clinical Study Report. February 2005. Data on file, Ucyclyd Pharma, Inc.
Urea Cycle Animation